Profusa (NASDAQ: PFSA) is quickly building momentum across Europe, adding leading vascular specialists to its clinical network while also preparing…
Read More »Top Stories
Gold (XAUUSD) has shattered yet another record, closing above $3,560 an ounce and cementing its role as 2025’s standout asset.…
Read More »
Rezolve AI (NASDAQ: RZLV) is a generative AI company disrupting the retail and e-commerce landscape. With strategic alliances, fresh capital,…
Read More »
Polymarket, the blockchain-based prediction platform once forced to block American users, has secured the long-awaited green light to reenter the…
Read More »
Solidion Technology (NASDAQ: STI) lit up the market on Wednesday, soaring 113% after announcing its latest recognition in the clean…
Read More »
Why Profusa Stands Out in Small-Cap Investing Profusa (NASDAQ: PFSA) is a biotech company that is developing tissue‑integrating biosensors for…
Read More »
Bitcoin (BTCUSD) climbed as high as $124,200 on August 14, touching another record high as investors embraced riskier assets amid…
Read More »
Tharimmune (NASDAQ: THAR) stunned Wall Street on Wednesday, with its stock surging more than 200% after announcing positive simulation results…
Read More »
For years, congressional stock trading has sparked outrage, suspicion, and fascination. Some lawmakers and their spouses appear to have uncanny…
Read More »
Profusa (NASDAQ: PFSA) is ramping up its leadership team just as the company accelerates efforts to commercialize its groundbreaking biosensor…
Read More »